Responsiveness of the ACTIVLIM‐CP questionnaire: measuring global activity performance in children with cerebral palsy
Open Access
- 4 June 2018
- journal article
- research article
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 60 (11) , 1178-1185
Abstract
Aim: To investigate the responsiveness of the ACTIVLIM‐CP questionnaire after two evidence‐based interventions for children with cerebral palsy (CP).Method: Seventy‐five children with CP either participated in an intensive motor‐skill learning intervention (hand–arm bimanual intensive therapy including lower extremities [HABIT‐ILE], n=47) or received botulinum neurotoxin‐A (BoNT‐A) injection(s) into lower extremities combined with conventional physical therapy (n=28). All children were assessed three times: at baseline (T0; before HABIT‐ILE/the day of BoNT‐A injection), at T1 (last day of HABIT‐ILE/6wks after BoNT‐A injection), and at follow‐up (T2; 3–4mo after the beginning of intervention). Parents completed ACTIVLIM‐CP and three other activity questionnaires. Responsiveness was analysed using group (based on intervention), subgroup (based on gross motor function level), and individual approaches.Results: For the HABIT‐ILE group, significant improvements in ACTIVLIM‐CP were observed for the T0–T1 period (pT1–T2 period. No significant changes were found in the BoNT‐A group during assessments (p=0.84). In the subgroup analysis for the HABIT‐ILE group (T0–T1), greater changes were demonstrated for children in Gross Motor Function Classification System levels III and IV (p<0.001, effect size=1.36). The individual approach was congruent with the group approach.Interpretation: ACTIVLIM‐CP demonstrated high responsiveness after HABIT‐ILE, showing that this scale may be used to investigate global activity performance in clinical trials focusing on improving daily life activities.What this paper adds: Good responsiveness of ACTIVLIM‐CP questionnaire during intensive motor‐skill learning intervention. Higher responsiveness for children in Gross Motor Function Classification System (GMFCS) levels III and IV versus I and II after intensive intervention. ACTIVLIM‐CP is useful to identify children improving their performance after botulinum neurotoxin‐A injection.Keywords
Funding Information
- Fonds de soutien Marguerite-Marie Delacroix
This publication has 22 references indexed in Scilit:
- A systematic review of interventions for children with cerebral palsy: state of the evidenceDevelopmental Medicine & Child Neurology, 2013
- Can manual ability be measured with a generic ABILHAND scale? A cross-sectional study conducted on six diagnostic groupsBMJ Open, 2012
- Anticipatory postural adjustments in children with hemiplegia and diplegiaJournal of Electromyography and Kinesiology, 2011
- Computer adaptive test performance in children with and without disabilities: prospective field study of the PEDI-CATDisability and Rehabilitation, 2011
- Development and evidence of validity for the Children’s Hand-use Experience Questionnaire (CHEQ)Developmental Medicine & Child Neurology, 2011
- The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliabilityDevelopmental Medicine & Child Neurology, 2007
- The Combined Effect of Lower-Limb Multilevel Botulinum Toxin Type A and Comprehensive Rehabilitation on Mobility in Children With Cerebral Palsy: A Randomized Clinical TrialArchives of Physical Medicine and Rehabilitation, 2006
- The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliabilityDevelopmental Medicine & Child Neurology, 2006
- ABILHAND-KidsNeurology, 2004
- Measurement properties of the Activities Scale for KidsJournal of Clinical Epidemiology, 2000